Finance

Lists
FRE:ETR
Fresenius SE & Co KGaA
€47.15
+0.51%
(+0.24) 1D
Aug 11, 5:35:20 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FRE...
Open
€47.20
High
€47.58
Low
€46.86
Mkt. cap
26.57B
Avg. vol.
1.03M
Volume
686.04K
Dividend
2.23%
Quarterly dividend
€0.26
Ex-dividend date
May 25, 2026
P/E ratio
17.43
52-wk high
€52.96
52-wk low
€35.11
EPS
€2.71
Shares outstanding
563.24M
No. of employees
178K
Open
€47.20
High
€47.58
Low
€46.86
Mkt. cap
26.57B
Avg. vol.
1.03M
Volume
686.04K
Dividend
2.23%
Quarterly dividend
€0.26
Ex-dividend date
May 25, 2026
P/E ratio
17.43
52-wk high
€52.96
52-wk low
€35.11
EPS
€2.71
Shares outstanding
563.24M
No. of employees
178K
News stories
From web sources and news partners
Profile
Fresenius SE & Co. KGaA is a German multinational health care company based in Bad Homburg vor der Höhe. It provides products and services for dialysis in hospitals, as well as inpatient and outpatient medical care. The company is involved in hospital management and in engineering and services for medical centers and other health care facilities. The company was ranked 411th in the 2023 Forbes Global 2000 list. Wikipedia
About Fresenius SE & Co KGaA
CEOMichael Sen
Employees178K
Founded1912
HeadquartersBad Homburg, Hessen, Germany
SectorHealth care provider
Last report
Aug 5, 2026
Fiscal period
Q2 2026
EPS / Est. (EUR)
€0.83 / €0.89
-6.68%miss
Revenue / Est. (EUR)
5.94B / 5.84B
+1.85%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.48B
6.16B
5.82B
5.94B
Cost of goods sold
4.18B
4.63B
4.28B
4.40B
Cost of revenue
4.18B
4.63B
4.28B
4.40B
Research and development expenses
159.00M
161.00M
163.00M
167.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
676.00M
824.00M
743.00M
760.00M
Operating expense
834.00M
859.60M
940.00M
918.00M
Total operating expenses
5.02B
5.49B
5.22B
5.31B
Operating income
466.00M
664.40M
595.00M
632.00M
Other non operating income
28.00M
15.00M
12.00M
-7.00M
EBT including unusual items
479.00M
607.00M
577.00M
535.00M
EBT excluding unusual items
479.00M
609.40M
570.00M
535.00M
Income tax expense
116.00M
180.00M
132.00M
136.00M
Effective tax rate
24.22%
29.65%
22.88%
25.42%
Other operating expenses
-1.00M
-125.40M
34.00M
-9.00M
Net income
344.00M
361.00M
435.00M
382.00M
Net profit margin
6.27%
5.86%
7.48%
6.43%
Earnings per share
0.82
0.96
0.99
0.83
Interest and investment income
-
116.00M
-
-
Interest expense
-81.00M
-197.00M
-69.00M
-73.00M
Net interest expenses
-81.00M
-81.00M
-69.00M
-73.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
731.00M
850.90M
857.00M
890.00M
Gain or loss from assets sale
-6.00M
-84.00M
6.00M
-4.00M
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps